Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Allogeneic Hematopoietic Stem Cell Recipients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 11 of 0 results

Not applicableNot Yet RecruitingNCT07324291
What this trial is testing

Perianal MBL-CRE Colonization and Infection in Allogeneic Hematopoietic Stem Cell Transplant Patients

Who this might be right for
ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATIONCarbapenem-resistant Enterobacterales
Institute of Hematology & Blood Diseases Hospital, China 1,000
Not applicableNot Yet RecruitingNCT06704542
What this trial is testing

Abnormal Glucose Tolerance in Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATIONDiabetes MellitusImpaired Fasting Glucose
Ruijin Hospital 1,000
Large-scale testing (Phase 3)Study completedNCT02474290
What this trial is testing

Sorafenib for Prophylaxis of Leukemia Relapse in Allo-HSCT Recipients With FLT3-ITD Positive AML

Who this might be right for
Acute Myeloid LeukemiaHematopoietic Stem Cell Transplantation
Nanfang Hospital, Southern Medical University 202
Not applicableStudy completedNCT00079222
What this trial is testing

Voriconazole Compared With Itraconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Cancer
Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)WithdrawnNCT00766285
What this trial is testing

High Dose Influenza in Immunosuppressed Subjects

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID)
Not applicableNo Longer AvailableNCT02258490
What this trial is testing

Expanded Use of G-CSF Mobilized Donor CD34+ Selected Cells for Allogeneic Transplantation

Who this might be right for
Chronic Myeloid LeukemiaMyelodysplastic SyndromeAcute Myeloid Leukemia
Emory University
Testing effectiveness (Phase 2)Active Not RecruitingNCT02269150
What this trial is testing

Autologous Fecal Microbiota Transplantation (Auto-FMT) for Prophylaxis of Clostridium Difficile Infection in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Allogeneic Hematopoietic Stem Cell
Memorial Sloan Kettering Cancer Center 59
Testing effectiveness (Phase 2)Study completedNCT02396134
What this trial is testing

Vaccine Therapy in Reducing the Frequency of Cytomegalovirus Events in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant

Who this might be right for
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+11 more
City of Hope Medical Center 61
Not applicableUnknownNCT06242496
What this trial is testing

Brain Abscesses in Transplant Recipients: a Multicentre Retrospective Study (BAT-STUDY)

Who this might be right for
Brain Abscess
Assistance Publique - Hôpitaux de Paris 200
Large-scale testing (Phase 3)Study completedNCT00169728
What this trial is testing

Vaccination of Children Following Allogeneic Stem Cell Transplantation

Who this might be right for
Allogeneic Haematopoietic Stem Cell Transplantation
Heinrich-Heine University, Duesseldorf 53
Testing effectiveness (Phase 2)Study completedNCT01665677
What this trial is testing

Atorvastatin as GVHD Prophylaxis for Allogeneic Hematopoietic Cell Transplantation

Who this might be right for
Graft vs Host Disease
Mehdi Hamadani 69